OBJECTIVES: This study was designed to assess the impact of crystalloid cardioplegia (CCP) and blood cardioplegia (BCP) on short-and long-term outcome after isolated aortic valve replacement (AVR).
INTRODUCTION
Aortic valve replacement (AVR) is the therapy of choice for many patients suffering from severe aortic valve disease. Postoperative outcome, however, can be compromised by serious adverse events such as low cardiac output syndrome (LCOS) that can result from insufficient intraoperative myocardial protection [1] . The convenience of a bloodless and motionless operating field during open-heart procedures comes at the price of myocardial damage, characterized as ischaemia-reperfusion injury [2] . Various solutions have been introduced during the past decades and many modifications have been considered in order to minimize this injury [3] [4] [5] 7] . Experimental studies suggest that intermittently applied blood cardioplegia (BCP) provides superior myocardial preservation due to its more physiological properties and oxygen-carrying capacity [5, 8] . In contrast to coronary artery bypass grafting (CABG), trial data for myocardial preservation methods during valve surgery are limited. Thus, the choice of a particular solution is based less on evidence than on technical considerations and surgeon preferences. The impetus for utilizing crystalloid solutions stems from the high likelihood of a singledose application, making them attractive for valve procedures or minimally invasive surgery requiring an arrested heart [9] . Conventional solutions such as Custodiol V R (HTK-Bretschneider, Dr Franz Köhler Chemie, Alsbach-H€ anhlein, Germany) or custom-made blood cardioplegia solutions according to Calafiore et al. [7] have been in use for >20 years; however, since patient demographics and perioperative care have evolved rapidly during this time, it has become necessary to re-evaluate contemporary preservation strategies.
This large, single-centre study was undertaken with the aim of determining clinical outcomes between cold BCP and cold †Presented at the 30th Annual Meeting of the European Association for Cardio-Thoracic Surgery, Barcelona, Spain, 1-5 October 2016. ‡The first two authors contributed equally to this study. crystalloid cardioplegia (CCP) in patients undergoing isolated aortic valve surgery.
PATIENTS AND METHODS

Data source
Clinical, operative and outcome data were collected in a computerized institutional database of the Department of Cardiothoracic Surgery at the University of Leipzig for all patients undergoing cardiac surgery between 1994 and 2015. A retrospective review of the database identified 7263 consecutive patients who underwent isolated AVR. Between 1994 and 2015, 7005 patients received either cold CCP in the form of Custodiol V R (HTK-Bretschneider solution, Dr Franz Köhler Chemie) or cold BCP according to Calafiore et al. [7] . Patients with major concomitant procedures were excluded from further analysis, minor concomitant procedures such as septal myectomy according to Morrow or surgical ablation of atrial fibrillation were included. The institutional review board at the University of Leipzig approved this research; additional patient consent was not required.
Surgical technique
HTK-Bretschneider solution (Custodiol V R ) was used as a crystalloid substitute with an administration temperature of 5-8 C, as originally described by Bretschneider et al. [4] . If aortic cross-clamp time (X-time) exceeded 90 min, the solution was routinely readministered. Application of the CCP solution was conducted as recommended by the manufacturer.
BCP was prepared according to the method followed by Calafiore et al., but the application temperature was modified by cooling to 15 C in contrast to the original description [7] . Induction of cardiac arrest was accomplished with high-dose ([K + ] 18-20 mEq/l) infusion and maintained by repeated delivery every 20 min with decreasing concentrations of potassium as previously described [7] .
Outcomes
Primary outcome was operative mortality (OM), which was defined as any postoperative death within 30 days of surgery. Secondary end-points were re-exploration for bleeding, LCOS, intra-aortic balloon pump implantation, extracorporeal membrane oxygenation implantation, myocardial infarction, cardiac arrhythmia, new pacemaker implantation, respiratory failure, renal failure requiring dialysis, cerebrovascular accident (permanent or transient), gastrointestinal complications, sepsis and symptomatic transitory psychotic syndrome. A combined end-point was defined as a composite of 30-day mortality, postoperative myocardial infarction, post-cardiac arrhythmia, dialysis and new pacemaker implantation.
Follow-up
Patients were monitored by the referring cardiologist and contacted periodically by our research personnel through either outpatient visits or telephone contact with patients or family members or both. Supplemental information was provided by family physicians and referring cardiologists. Our research personnel collected all follow-up data until July 2015. Follow-up was 100% complete and comprised 5729 patient years, corresponding to 3.5 years per patient.
Statistics
The propensity score was calculated from 28 preoperative characteristics (see Supplementary Material, Fig. S1 ). From 833 BCP and nearly 4000 CCP patients, 825 matched pairs (by caliper 0.25) could be formed (Fig. 1) [10] . We calculated standardized mean differences for continuous variables and odds ratios (ORs) for categorical variables to check the balance of baseline characteristics [27] . ORs near one and standardized mean differences near zero indicated a very good balance in all preoperative covariates.
Peri-and postoperative characteristics were described by numbers (percentage), means (±standard deviation, SD) and median (interquartile range) for some features with outliers like perioperative or laboratory characteristics. Accordingly groups were compared by the McNemar test for categorical data and paired t-test or Wilcoxon test for continuous data. We calculated ORs, standardized mean differences and non-parametric difference estimates including 99% confidence intervals (Hodges-Lehman) as effect measures. Overall and 30-day mortality and the composite endpoint were analysed by time-to-event methods. Survival curves were estimated and depicted using Kaplan-Meier methods.
We built multiple models in order to look for variables associated with the end-points and to adjust for possibly confounding covariates. Multiple conditional logistic regression models were fitted for OM and the composite end-point, conditional Cox regression for all-cause mortality. To select relevant variables, we used the LASSO procedure, least absolute selection and shrinkage operator implemented in the R package 'penalized' [11] . It enabled to select variables without considering P-values. Eventually, 'sparse' final models were fitted to get unbiased hazards ratio and OR estimates. A 2-tailed significance level of a = 1% was set for overall analyses, 5% for subgroup analyses. We performed data preparation, descriptive statistics and conditional Cox regression using IBM SPSS 22, propensity matching and the LASSO procedure using R 3.1.2 and the conditional logistic regression using SAS 9.3.
RESULTS
Exploratory analysis of 7005 consecutive patients undergoing isolated AVR (Table 1) revealed a different risk factor distribution between patients receiving CCP (n = 5998, mean age 66.7 ± 11.5; male: n = 3525, 58.8%) and BCP (n = 1007, mean age 68.3 ± 12.0; male n = 578, 57.4%). The main indicators for the use of BCP were low left ventricular ejection fraction [LVEF; OR 2.49 (1.9-3.1); P < 0.001] and prior cardiac surgery [OR 2.75 (2.1-3.4); P < 0.001]. Propensity score matching yielded 1650 patients for further analysis (Table 2) . Tables 3 and 4 , P < 0.001). Septal myectomy was more frequently carried out in BCP (CCP: 8%, n = 66; BCP: 11.3%, n = 93, P = 0.029).
INTRAOPERATIVE DATA
Details of surgical procedures are listed in
POSTOPERATIVE OUTCOMES AND LONG-TERM SURVIVAL
Postoperative data are shown in Table 5 . OM was 4.0% (n = 33) for CCP and 4.2% for BCP patients (P = 0.90). For elective surgical patients, OM was 2.1% in CCP and 2.5% in BCP. Incidence of LCOS was low and not different between the groups (BCP and CCP: 23 (2.8%), OR: 1.00 (0.55-1.79), P = 1.00). Cardiac arrhythmias were (Fig. 2) .
MULTIPLE MODELS AND SUBGROUP ANALYSIS
After adjustment for relevant covariates, there was only a slightly higher and not significant risk for BCP patients to meet the different end-points (Table 6 ). Short-and long-term mortality and the combined end-point were much stronger associated with age and comorbid conditions represented by renal dysfunction (glomerular filtration rate), EuroSCORE and diabetes. A higher incidence of the combined end-point was observed in BCP patients with acute infective endocarditis (CCP: 36%, n = 27; BCP: 51.9%, n = 41; P = 0.047). There were markedly more patients with LVEF < _30% in the BCP group (CCP 6.6% vs BCP 10.5%, P = 0.006). However, 27 of 53 (51%) CCP patients and 26 of 83 (31%) BCP patients with low LVEF died during long-term follow-up [OR: 2.28 (1.12-4.63); P = 0.03].
DISCUSSION
Elective cardiac arrest as achieved by cardioplegic solutions is one of the critical steps during open-heart procedures such as AVR. Different experimental animal studies have suggested a better myocardial protection with BCP [8, 24] . Clinical evaluations of different myocardial preservation techniques, however, show inconsistent results when comparing CCP with BCP in isolated valve repair [9, 14, 24, 25] . Also, previous prospective randomized clinical trials focusing on CABG did not demonstrate a persuasive clinical superiority of BCP over CCP regarding mortality or perioperative myocardial infarction [13] .
Although in aortic valve pathologies, coronary flow is not hindered by coronary obstruction, poor distribution of cardioplegic solutions has been described as a consequence of microcirculatory dysfunction in hypertrophied myocardium as described by Rajappan et al. [14] . Dilated epicardial coronary arteries, reduced capillary density and decreased vascular dilatation reserve in the subendocardial area have been discussed in this regard [14, 15] . However, the results of the present study show that there were no significant differences in postoperative outcome between both cardioplegic solutions regarding hard end-points such as OM and end-points such as LCOS, myocardial infarction or renal failure. This finding is in line with the largest prospective, randomized, single-centre trial to date comparing BCP and CCP that was recently published by Øvrum et al. [16] . They compared a potassium-enriched Ringer-lactate solution with a blood-based cardioplegic solution and found no significant differences in early mortality and overall postoperative complications. It should be mentioned that 50% of the patients in this trial required additional CABG due to relevant coronary artery disease, and the reported event rate of the primary end-point was small; thus, it is likely that the study was underpowered [16] . Altogether, the results of the present study are in accordance with the findings of Øvrum et al. except for cross-clamp times, which were longer in the CCP group in our cohort. Braathen et al. and Beyersdorf et al. found also shorter cross-clamp times, in patients operated on with BCP [9, 17] . The reason for this finding could be that Custodiol must be infused for 6-8 min in order to achieve its full effect. However, the difference between the groups is of questionable clinical impact.
There was a trend towards a higher incidence of the occurrence of postoperative arrhythmias in the BCP group in the present trial. Congruously Sakata et al. compared HTK solution with cold BCP in isolated mitral valve surgery and found more spontaneous defibrillation and a lower rate of conductance abnormalities during reperfusion in the HTK group. The BCP solution used was a mixture of blood with HTK in a 1:1 ratio [24] .
The impetus for using crystalloid solutions like Custodiol V R , which was formulated by Bretschneider during the 1970s, was to achieve a bloodless and motionless operation field after singledose application [6] . In contrast to the case for repetitive administrations of BCP, the heart remains completely ischaemic during arrest. Additives are used in order to diminish ischaemiareperfusion injury by facilitating better recovery of postischaemic biochemical and mechanical properties as well as endothelial protection [18] . The technical advantages of crystalloid solutions, however, are conferred by the possibility of using an antegrade, single-dose application, making this type of cardioplegia particularly interesting for open-heart procedures like AVR or especially for minimally invasive surgery [9, 19] . With a minimally invasive approach, a clear and unobstructed view is of particular importance, and this can be better achieved with CCP than repetitive application of BCP [20] .
In the present study, subgroup analyses revealed similar outcomes for patients with prolonged ischaemia or gender but a higher incidence of the combined end-point in patients with acute infective endocarditis. Myocardial preservation methods in patients undergoing aortic valve surgery due to acute infective endocarditis are still under-reported [21] . For patients with a low LVEF, the present results suggest superior long-term survival when BCP was used intraoperatively. This difference cannot unambiguously be traced back to the cardioplegia type. Similarly, to the whole cohort, comorbidity conditions like diabetes and glomerular filtrations rate were multiply significantly associated. However, Jin et al. recently suggested that treatment of myocardial dysfunction with catecholamine infusion can be avoided when myocardial protection is achieved with cold BCP in contrast to warm BCP or CCP by assessing changes in regional and global left ventricular function early after AVR [12] . A subgroup analysis of the CABG Patch trial also suggested that BCP is superior to CCP in patients with advanced left ventricular dysfunction [22] .
There are several limitations to this study. Due to its retrospective nature, there is a risk of selection bias; we attempted to minimize this bias with propensity score matching, although we are aware that matching cannot replace the randomization used in prospective randomized trials. Another limitation is that the surrogate parameters that were used for the definition of the primary and secondary end-points are influenced by various factors and were not defined prospectively. Whether subgroup analyses from propensity-matched cohorts are reliable is a matter of debate [23] ; however, the comorbidity defining the particular subgroup was not prospectively defined and was thus potentially biased. Furthermore, the echocardiographic estimates of LVEF may be a cause of concern. The use of echocardiography in this clinical setting, however, is standard clinical practice.
CONCLUSIONS
This study reports one of the largest clinical experiences to date. The algorithm used at our institution, where CCP is the standard method for cardioplegic arrest in valve surgery but where cold BCP is used for high-risk patients, allowed us to examine this clinical question. It can be concluded that CCP produces at least as good operative results as BCP in terms of operative mortality and postoperative complications. The best solution for cardioplegic arrest and myocardial protection, however, remains unknown, and investigations focusing on patients with comorbidities like low LVEF, which might significantly influence the susceptibility of the myocardium to ischaemia-reperfusion injury, need to be conducted in the future.
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